These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20570743)

  • 121. Optimizing the experimental environment for dog telemetry studies.
    Klumpp A; Trautmann T; Markert M; Guth B
    J Pharmacol Toxicol Methods; 2006; 54(2):141-9. PubMed ID: 16730461
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: current recommendations from the Safety Pharmacology Society.
    Leishman DJ; Beck TW; Dybdal N; Gallacher DJ; Guth BD; Holbrook M; Roche B; Wallis RM
    J Pharmacol Toxicol Methods; 2012; 65(3):93-101. PubMed ID: 21907296
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Social-housing and use of double-decker cages in rat telemetry studies.
    Skinner M; Ceuppens P; White P; Prior H
    J Pharmacol Toxicol Methods; 2019; 96():87-94. PubMed ID: 30779962
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Combined Cardiopulmonary Assessments Using Impedance and Digital Implants in Conscious Freely Moving Cynomolgus Monkeys, Beagle Dogs, and Göttingen Minipigs: Pharmacological Characterization and Social Housing Effects.
    Boulay E; Troncy E; Pugsley M; St-Pierre J; Downey AM; Smutova V; Guerrier M; Maghezzi S; Authier S
    Int J Toxicol; 2021 Dec; 40(6):530-541. PubMed ID: 34610777
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Biological variations in hemodynamics and electrocardiogram rhythms among telemetered cynomolgus monkeys.
    Hong M; Wei L; Duan H; Chen T; Shi L; You Y; Chen Y; Li H; Ma J
    J Pharmacol Toxicol Methods; 2021; 112():107108. PubMed ID: 34363962
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization.
    Alizadeh EA; Graf K; Schiwon J; Trautmann T; Krause F; Mayer W; Christ K; Martel E; Guth BD; Markert M
    J Pharmacol Toxicol Methods; 2023; 122():107279. PubMed ID: 37257761
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Automated blood sampling in canine telemetry model: Enhanced assessment of immune liabilities.
    Koshman YE; Lai-Zhang J; Wilsey AS; Bird BM; Sadilek S; Weisbecker DA; Ebert PA; Polakowski JS; Mittelstadt SW; Foley CM; LeRoy BE
    J Pharmacol Toxicol Methods; 2021; 112():107115. PubMed ID: 34403748
    [TBL] [Abstract][Full Text] [Related]  

  • 128. [Technology and evaluation best practices for in vivo cardiovascular safety pharmacology studies].
    Ozaki H
    Nihon Yakurigaku Zasshi; 2021; 156(6):364-369. PubMed ID: 34719571
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Influence of surgically implantable telemetry solutions on in-life and post-mortem toxicology endpoints.
    Baird TJ; Bailie M; Patrick DJ; Moddrelle D; Yoder J; Gauvin DV; Dalton JA
    J Pharmacol Toxicol Methods; 2013; 67(3):148-61. PubMed ID: 23438450
    [TBL] [Abstract][Full Text] [Related]  

  • 130. The impact of environmental and biological factors on the resting heart rate of dogs as assessed using 20 years of data from safety pharmacology studies.
    Alizadeh EA; Trautmann T; Krause F; Knoeferl B; Guns PJ; De Meyer G; Guth BD; Markert M
    J Pharmacol Toxicol Methods; 2023; 121():107263. PubMed ID: 36965603
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Semi-mechanistic modelling platform to assess cardiac contractility and haemodynamics in preclinical cardiovascular safety profiling of new molecular entities.
    Venkatasubramanian R; Collins TA; Lesko LJ; Mettetal JT; Trame MN
    Br J Pharmacol; 2020 Aug; 177(15):3568-3590. PubMed ID: 32335903
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Exploratory EEG studies for the assessment of neurological liabilities in conscious dogs in early drug development.
    Breidenbach L; Potschka H; Hempel K
    J Pharmacol Toxicol Methods; 2019; 98():106581. PubMed ID: 31102738
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Preclinical safety assessments of nano-sized constructs on cardiovascular system toxicity: A case for telemetry.
    Cheah HY; Kiew LV; Lee HB; Japundžić-Žigon N; Vicent MJ; Hoe SZ; Chung LY
    J Appl Toxicol; 2017 Nov; 37(11):1268-1285. PubMed ID: 28165137
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Cardiovascular pressure measurement in safety assessment studies: technology requirements and potential errors.
    Sarazan RD
    J Pharmacol Toxicol Methods; 2014; 70(3):210-23. PubMed ID: 24933393
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Preclinical to Clinical Translation of Hemodynamic Effects in Cardiovascular Safety Pharmacology Studies.
    Bhatt S; Northcott C; Wisialowski T; Li D; Steidl-Nichols J
    Toxicol Sci; 2019 May; 169(1):272-279. PubMed ID: 30726989
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog.
    Antic O; Koshman YE; Bird BM; Jasiek G; Wilsey AS; Mittelstadt SW; Foley CM
    J Pharmacol Toxicol Methods; 2024; 126():107497. PubMed ID: 38479593
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Correcting the QT interval for changes in HR in pre-clinical drug development.
    Meyners M; Markert M
    Methods Inf Med; 2004; 43(5):445-50. PubMed ID: 15702198
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Chronic monitoring of cardiovascular function in the conscious guinea pig using radio-telemetry.
    DePasquale MJ; Ringer LW; Winslow RL; Buchholz RA; Fossa AA
    Clin Exp Hypertens; 1994 Mar; 16(2):245-60. PubMed ID: 8193612
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Synthesis and hypotensive properties of new 4-aminoquinolines.
    Wright GC; Watson EJ; Ebetino FF; Lougheed G; Stevenson BF; Winterstein A; Bickerton RK; Halliday RP; Pals DT
    J Med Chem; 1971 Nov; 14(11):1060-6. PubMed ID: 5115204
    [No Abstract]   [Full Text] [Related]  

  • 140. Effect of diet on the cardiovascular system in healthy beagles.
    Nakagawa K; Miyagawa Y; Takemura N; Hirose H
    J Vet Med Sci; 2010 May; 72(5):615-9. PubMed ID: 20009430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.